tm logo
Live/Registered
REGISTERED

on 04 Apr 2023

Last Applicant/ Owned by

NL-1077 MX Amsterdam

PL

Serial Number

79321010 filed on 02th Aug 2021

Registration Number

7014557 registered on 04th Apr 2023

in the Principal Register

Correspondent Address

Alexander Lazouski

LAZOUSKI IP LLC

SUITE 1, 14726 BOWFIN TER.

LAKEWOOD RANCH, FL 34202

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

Logo Mark Trademark Information

The color(s) green is/are claimed as a feature of the mark. Pharmaceutical products, namely, pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical products, namely, pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; medical and veterinary pharmaceutical preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biotechnological preparations for medical, pharmaceutical and veterinary purposes, namely, biotechnological preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biological preparations for medical, pharmaceutical and veterinary purposes, namely, biological preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; biological implants, namely, a vital processed human or animal connective tissue; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, preparations for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; chemico pharmaceutical preparations, namely, preparations for pharmaceutical or medical purposes for the treatment of viral, infectious, parasitic, metabolic, endocrine, nutritional, musculoskeletal, cardiovascular, cardiopulmonary, circulatory system diseases, genitourinary, pregnancy, childbirth, puerperium and perinatal period disorders, developmental anomalies, sexual dysfunction, oncological, hepatological, hematological, ophthalmic, otolaryngological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, behavioural, neurodevelopmental, sleep-wake and immune system related diseases and disorders; sanitary preparations for medical purposes; dietetic foods and substances adapted for medical or veterinary use, namely, dietetic preparations adapted for medical purposes, dietetic foods adapted for medical use, dietetic sugar substitutes for medical use; dietary supplements for human beings and animals; medical plasters, materials for dressings, namely, sterilized dressing, bandages for dressings, wadding for dressings; disinfectants; preparations for destroying vermin

Mark Details


Serial Number

No 79321010

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Design Code(s)

24.01.02 -

Shields or crests with figurative elements contained therein or superimposed thereon

26.05.15 -

Four or more triangles

26.05.21 -

Triangles that are completely or partially shaded

26.15.21 -

Polygons that are completely or partially shaded

26.15.25 -

Polygons with one or more curved sides

Description of Design Search

The mark consists of a design of a shield, outlined in a green line with a green solid triangle on each side of the upper portion of the shield, with a green polygon inside at the top, with two green connecting triangles at each side underneath. The color white represents background, outlining, shading and/or transparent areas and is not part of the mark.

Legal History


Show more

Status DateAction Taken
14th Aug 2023FINAL DECISION TRANSACTION PROCESSED BY IB
21st Jul 2023FINAL DISPOSITION PROCESSED
21st Jul 2023FINAL DISPOSITION NOTICE SENT TO IB
04th Jul 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04th Apr 2023REGISTERED-PRINCIPAL REGISTER
04th Apr 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
20th Mar 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01st Mar 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01st Mar 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
26th Jan 2023NOTIFICATION PROCESSED BY IB